Cargando…

PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES

Detalles Bibliográficos
Autores principales: Manghisi, Beatrice, Alberti, Sara, Ripamonti, Alessia, Perfetti, Paola, Borin, Lorenza Maria, Fumagalli, Monica, Passerini, Carlo Gambacorti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429887/
http://dx.doi.org/10.1097/01.HS9.0000974344.83336.78
_version_ 1785090823313948672
author Manghisi, Beatrice
Alberti, Sara
Ripamonti, Alessia
Perfetti, Paola
Borin, Lorenza Maria
Fumagalli, Monica
Passerini, Carlo Gambacorti
author_facet Manghisi, Beatrice
Alberti, Sara
Ripamonti, Alessia
Perfetti, Paola
Borin, Lorenza Maria
Fumagalli, Monica
Passerini, Carlo Gambacorti
author_sort Manghisi, Beatrice
collection PubMed
description
format Online
Article
Text
id pubmed-10429887
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104298872023-08-17 PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES Manghisi, Beatrice Alberti, Sara Ripamonti, Alessia Perfetti, Paola Borin, Lorenza Maria Fumagalli, Monica Passerini, Carlo Gambacorti Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429887/ http://dx.doi.org/10.1097/01.HS9.0000974344.83336.78 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Manghisi, Beatrice
Alberti, Sara
Ripamonti, Alessia
Perfetti, Paola
Borin, Lorenza Maria
Fumagalli, Monica
Passerini, Carlo Gambacorti
PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title_full PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title_fullStr PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title_full_unstemmed PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title_short PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES
title_sort pb1879: efficacy and safety of cpx-351 compared to standard of care chemotherapy in a real-life setting: supporting previous evidence and facing new challenges
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429887/
http://dx.doi.org/10.1097/01.HS9.0000974344.83336.78
work_keys_str_mv AT manghisibeatrice pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT albertisara pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT ripamontialessia pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT perfettipaola pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT borinlorenzamaria pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT fumagallimonica pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges
AT passerinicarlogambacorti pb1879efficacyandsafetyofcpx351comparedtostandardofcarechemotherapyinareallifesettingsupportingpreviousevidenceandfacingnewchallenges